I was heartened to just learn that researchers from the Hadassah-Hebrew Medical Center in Jerusalem are receiving a $1.33 million grant from the Israeli government to advance their development of a stem cell treatment for people with dry age-related macular degeneration (AMD Hadassah is also funded by the Foundation Fighting Blindness. We are providing the group with a three-year, $300,000 grant for development of stem cell therapies.
The Wailing Wall, Israel
So, my prayers were answered. As I mentioned in my last post, my luggage did not arrive with me in Israel, but, as the airlines promised, it did a day later, so I haven’t had to keep wearing the same clothes. Thank goodness.
Continue Reading…
Technion University, Haifa, Israel
If anyone knows the Hebrew blessing for the return of lost luggage, please share. I know it goes something like: Baruch Atah Adonai, etc., etc. etc. Thankfully, I packed a carry-on, so I am in good shape for now.
David Brint, FFB board member and my travelling companion, and I are excited to be here. Today was a bright beautiful day, and we were in a modern community called Tel Hashomer, close to Tel Aviv. It’s known for its large defense base and the Sheba Medical Center, which was our first destination for the day.
Continue Reading…
Tel Aviv, Israel
Next week is a big week for both me and the Foundation. I’ll be heading to Israel, for the first time in my life, to visit with Foundation business and research partners. So the next couple blog posts you see will come straight from places like Haifa, Jerusalem and Tel Aviv.
Steve is highly respected for his expertise and tireless commitment to finding treatments and cures for vision-robbing retinal diseases. Read More...
As the Foundation's senior science writer, Ben writes science and research articles for the Foundation’s website, newsletters and Eye on the Cure blog. Read More...
As the Foundation's senior writer, Rich writes and edits content for all of the Foundation’s print and online publications, including its blog, Eye on the Cure. Read More...
